Medicines Co. (MDCO) Reports Q3 Loss Per Share of $1.19, Less Than Expected

October 25, 2017 7:10 AM EDT

Medicines Co. (NASDAQ: MDCO) reported Q3 EPS of ($1.19), $0.25 better than the analyst estimate of ($1.44). Revenue for the quarter came in at $16.9 million versus the consensus estimate of $24.35 million.

For earnings history and earnings-related data on Medicines Co. (MDCO) click here.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Earnings, Guidance

Related Entities

Earnings